Ilin IS - Search Results

1

New Hybrid Tetrahydropyrrolo[3,2,1-ij]quinolin-1-ylidene-2-thioxothiazolidin-4-ones as New Inhibitors of Factor Xa and Factor XIa: Design, Synthesis, and In Silico and Experimental Evaluation.

Novichikhina NP, Shestakov AS, Medvedeva SM, Lagutina AM, Krysin MY, Podoplelova NA, Panteleev MA, Ilin IS, Sulimov AV, Tashchilova AS, Sulimov VB, Geronikaki A, Shikhaliev KS. Novichikhina NP, et al. Among authors: ilin is. Molecules. 2023 May 1;28(9):3851. doi: 10.3390/molecules28093851. Molecules. 2023. PMID: 37175261 Free PMC article.

2

New generation of docking programs: Supercomputer validation of force fields and quantum-chemical methods for docking.

Sulimov AV, Kutov DC, Katkova EV, Ilin IS, Sulimov VB. Sulimov AV, et al. Among authors: ilin is. J Mol Graph Model. 2017 Nov;78:139-147. doi: 10.1016/j.jmgm.2017.10.007. Epub 2017 Oct 12. J Mol Graph Model. 2017. PMID: 29055806

3

New factor Xa inhibitors based on 1,2,3,4-tetrahydroquinoline developed by molecular modelling.

Ilin I, Lipets E, Sulimov A, Kutov D, Shikhaliev K, Potapov A, Krysin M, Zubkov F, Sapronova L, Ataullakhanov F, Sulimov V. Ilin I, et al. J Mol Graph Model. 2019 Jun;89:215-224. doi: 10.1016/j.jmgm.2019.03.017. Epub 2019 Mar 16. J Mol Graph Model. 2019. PMID: 30913501

4

[Docking with combined use of a force field and a quantum-chemical method].

Sulimov AV, Kutov DK, Ilin IS, Sulimov VB. Sulimov AV, et al. Among authors: ilin is. Biomed Khim. 2019 Feb;65(2):80-85. doi: 10.18097/PBMC20196502080. Biomed Khim. 2019. PMID: 30950811 Russian.

5

Supercomputer docking with a large number of degrees of freedom.

Sulimov A, Kutov D, Ilin I, Zheltkov D, Tyrtyshnikov E, Sulimov V. Sulimov A, et al. SAR QSAR Environ Res. 2019 Oct;30(10):733-749. doi: 10.1080/1062936X.2019.1659412. Epub 2019 Sep 24. SAR QSAR Environ Res. 2019. PMID: 31547677

6

Synthesis, Docking, and In Vitro Anticoagulant Activity Assay of Hybrid Derivatives of Pyrrolo[3,2,1-ij]Quinolin-2(1H)-one as New Inhibitors of Factor Xa and Factor XIa.

Novichikhina N, Ilin I, Tashchilova A, Sulimov A, Kutov D, Ledenyova I, Krysin M, Shikhaliev K, Gantseva A, Gantseva E, Podoplelova N, Sulimov V. Novichikhina N, et al. Molecules. 2020 Apr 19;25(8):1889. doi: 10.3390/molecules25081889. Molecules. 2020. PMID: 32325823 Free PMC article.

7

Docking Paradigm in Drug Design.

Sulimov VB, Kutov DC, Taschilova AS, Ilin IS, Tyrtyshnikov EE, Sulimov AV. Sulimov VB, et al. Among authors: ilin is. Curr Top Med Chem. 2021;21(6):507-546. doi: 10.2174/1568026620666201207095626. Curr Top Med Chem. 2021. PMID: 33292135 Review.

8

[Development of antiviral drugs based on inhibitors of the SARS-COV-2 main protease].

Sulimov AV, Shikhaliev KS, Pyankov OV, Shcherbakov DN, Chirkova VY, Ilin IS, Kutov DC, Tashchilova AS, Krysin MY, Krylskiy DV, Stolpovskaya NV, Volosnikova EA, Belenkaya SV, Sulimov VB. Sulimov AV, et al. Among authors: ilin is. Biomed Khim. 2021 May;67(3):259-267. doi: 10.18097/PBMC20216703259. Biomed Khim. 2021. PMID: 34142533 Russian.

9

Quantum-Chemical Quasi-Docking for Molecular Dynamics Calculations.

Sulimov A, Kutov D, Ilin I, Sulimov V. Sulimov A, et al. Nanomaterials (Basel). 2022 Jan 15;12(2):274. doi: 10.3390/nano12020274. Nanomaterials (Basel). 2022. PMID: 35055291 Free PMC article.

10

New Blood Coagulation Factor XIIa Inhibitors: Molecular Modeling, Synthesis, and Experimental Confirmation.

Tashchilova A, Podoplelova N, Sulimov A, Kutov D, Ilin I, Panteleev M, Shikhaliev K, Medvedeva S, Novichikhina N, Potapov A, Sulimov V. Tashchilova A, et al. Molecules. 2022 Feb 12;27(4):1234. doi: 10.3390/molecules27041234. Molecules. 2022. PMID: 35209023 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16 results

Search Page